Would you like to see your presentation here, made available to a global audience of researchers?
Add your own presentation or have us affordably record your next conference.
Allergen management and Quantitative Risk Assessment (QRA) play a critical role in informing Precautionary Allergen Labelling (PAL). These processes depend heavily on analytical data to provide evidence and validate assumptions. A noteworthy framework is the VITAL® program (Voluntary Incidental Trace Allergen Labelling), a standardized allergen risk assessment process widely used in the food industry. By evaluating allergens intentionally included and those introduced through cross contact, VITAL determines whether precautionary statements should appear on product labels. To support allergen management and validate QRA outcomes, the food industry employs a range of analytical methods. These methods vary in complexity, from simple protein swabs used for monitoring to highly specific ELISA-based techniques applied for compliance purposes. The data generated at different stages of the manufacturing process is integral to confirming risk assessment outcomes and underlying assumptions. Crucially, analytical methods must always be fit for their intended purpose, as inappropriate methods could undermine the reliability of results. Challenges persist in this domain, particularly with ensuring that analytical methods are sensitive enough for their applications and that reporting units are harmonized. Harmonization allows for easy comparison of results with calculated risk assessments. Collaboration between laboratories and Food Business Operators is essential to address these issues effectively, beginning well before analysis is undertaken. Recent findings by the FAO/WHO Ad Hoc Expert Committee for Food Allergens emphasize the need to overcome these barriers to ensure that allergen analysis meaningfully supports robust quantitative risk assessments. Current strategies addressing these challenges will be explored in the presentation.
